icon

Press Releases

Aptean Enters Healthcare Industry with Acquisition of Medworxx Solutions, Inc.

Atlanta, Oct. 15, 2015 — With the completion of its acquisition of Medworxx Solutions Inc., Aptean announced today its entrance into the healthcare industry. Medworxx is a leading provider of clinical patient flow, compliance and education solutions to more than 350 hospitals internationally, including Canada, France, the United States and the United Kingdom.

Medworxx files Q2/2015 financials

Toronto, Ontario, August 27, 2015 ‐ Medworxx Solutions Inc. ("Medworxx")(TSX VENTURE:MWX), a leader in clinical patient flow, and compliance and education solutions, announced today it has filed with the Canadian securities authorities its Consolidated Financial Statements and Management's Discussion and Analysis report for the quarter ended June 30, 2015. These documents may be viewed under the Company's profile at www.sedar.com.

Medworxx Solutions Inc. and Aptean, Inc. enter into definitive agreement for going private transaction

Toronto, August 27, 2015: Medworxx Solutions Inc. (TSXV: “MWX”) ("Medworxx" or the "Corporation"), a leader in clinical patient flow, and compliance and education solutions, and Aptean, Inc., through an affiliate (“Aptean”), a leading provider of industry-focused mission critical enterprise software solutions, with experience acquiring and growing highly profitable companies announced today that they have entered into a definitive arrangement agreement (the “Arrangement Agreement”) pursuant to which Aptean will beneficially acquire, in an all-cash transaction, all of the issued and outstanding class a common shares (the “Common Shares”) of the Corporation by way of a court-approved plan of arrangement under the Canada Business Corporations Act (the “Arrangement”).

NHS England Identifies Medworxx as an Official Clinical Utilisation Review (CUR) Provider The Framework Agreement gives NHS Trust access to CUR software procurement funds

TORONTO, July 14, 2015 , Medworxx Inc. (“Medworxx”) (TSXV: MWX), a leader in Clinical Utilisation Review (CUR) solutions, announced today that NHS England has selected Medworxx and three other patient flow solution providers as CUR Preferred Bidders. In 2014 NHS England introduced a Commissioning for Quality and Innovation scheme (CQUIN) to require mandatory adoption of CUR as a core capability to ensure the provision of safe and cost effective care.

Medworxx Patient Flow Solution continues to expand in the UK with adoption from Basildon and Thurrock University Hospitals NHS Foundation Trust

TORONTO, ONTARIO, July 8, 2015 – Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE: MWX) today announced Basildon and Thurrock University Hospitals NHS Foundation Trust (BTUH) has licensed the Medworxx Clinical Criteria Module to be installed in a

Community Regional Medical Center, California, U.S., expands use of Medworxx Patient Flow Platform by adding the Bed Management module and increasing Clinical Criteria licensing

TORONTO, ONTARIO, July 7, 2015 – Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE: MWX), a leading healthcare patient flow software solutions provider, is pleased to announce that Community Regional Medical Center (CRMC) has secured additional Medworxx Patient Flow Platform licenses. Community Regional Medical Center began working with Medworxx in February 2015 and has since implemented the Medworxx Clinical Criteria Module to support the facility’s advanced patient flow work.

Medworxx Announces Partnership Agreement with Aspen Medical, a Global Healthcare Solutions Firm in Australia

TORONTO, ONTARIO, June 30, 2015 – With strong traction in Canada and robust growth in the UK, Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE: MWX) today announced their partnership with Aspen Medical. The agreement will support Aspen Medical’s patient flow performance improvement consulting strategy in Australia and New Zealand.

Medworxx and the High Commission of Canada to the United Kingdom will Host a Clinical Utilisation Review Event at Canada House

TORONTO, ONTARIO, June 19, 2015 – Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE: MWX) announced today the company’s sponsorship of an interactive thought leadership event taking place at The High Commission of Canada headquarters in London, called Canada House, on June 22, 2015. Medworxx is slated to provide unique insight into improving hospital and health system integration performance.

Medworxx Patient Flow Solution expands beyond the Hospital Environment with adoption from Gloucestershire Care Services NHS Trust (GCS)

TORONTO, ONTARIO, May 28, 2015 – Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE: MWX) today announced Gloucestershire Care Services NHS Trust (GCS) has licensed the Medworxx Clinical Criteria Module and Forms and Assessments Module to be deployed across seven community hospitals, covering 260 beds. GCS provides a range of in-patient and out-patient services to Gloucestershire's population of approximately 600,000 people, including nursing, physiotherapy, reablement and adult social care services.

Medworxx retains profitability in Q1 while recognizing two million in revenue. International hospitals implement Clinical Criteria and contribute to Medworxx growth.

Toronto, Ontario, May 13, 2015 - Medworxx Solutions Inc. ("Medworxx")(TSX VENTURE:MWX), a leader in clinical patient flow, and compliance and education solutions, announced today it has filed with the Canadian securities authorities its Consolidated Financial Statements and Management's Discussion and Analysis report for the quarter ended March 31, 2015. These documents may be viewed under the Company's profile at www.sedar.com.

Pages